for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

West Pharmaceutical Services Inc.

WST

Latest Trade

275.72USD

Change

-9.01(-3.16%)

Volume

300,025

Today's Range

274.12

 - 

285.77

52 Week Range

124.53

 - 

305.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
284.73
Open
284.90
Volume
300,025
3M AVG Volume
9.54
Today's High
285.77
Today's Low
274.12
52 Week High
305.00
52 Week Low
124.53
Shares Out (MIL)
73.93
Market Cap (MIL)
21,049.29
Forward P/E
63.08
Dividend (Yield %)
0.24

Next Event

Q4 2020 West Pharmaceutical Services Inc Earnings Release

Latest Developments

More

West Says Approved Q4 Dividend Of $0.17 Per Share, A 6.25% Increase

West Announces Third-Quarter 2020 Earnings Per Share $1.09

West Pharmaceutical Services Reports Q2 Adj EPS Of $1.25

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Industry

Medical Equipment & Supplies

Contact Info

530 HERMAN O WEST DR

EXTON, PA

19341-1147

United States

+1.610.5942900

https://www.westpharma.com/

Executive Leadership

Patrick J. Zenner

Independent Chairman of the Board

Eric Mark Green

President, Chief Executive Officer, Director

Bernard John Birkett

Chief Financial Officer, Senior Vice President

David A. Montecalvo

Senior Vice President, Chief Operating and Supply Chain Officer

Annette F. Favorite

Chief Human Resource Officer, Senior Vice President

Key Stats

2.00 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

1.6K

2018

1.7K

2019

1.8K

2020(E)

2.1K
EPS (USD)

2017

2.780

2018

2.810

2019

3.240

2020(E)

4.540
Price To Earnings (TTM)
69.08
Price To Sales (TTM)
10.33
Price To Book (MRQ)
12.24
Price To Cash Flow (TTM)
52.37
Total Debt To Equity (MRQ)
14.88
LT Debt To Equity (MRQ)
14.74
Return on Investment (TTM)
14.85
Return on Equity (TTM)
12.40

Latest News

Latest News

BRIEF-West Pharmaceutical Services To Join S&P 500 Index

* WEST PHARMACEUTICAL SERVICES, INC. TO JOIN S&P 500 INDEX Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-West Pharmaceutical Services Says Q1 Adjusted Earnings Per Share $1.01

* Q1 EARNINGS PER SHARE ESTIMATE $0.82 -- REFINITIV IBES DATA

BRIEF-West Elects New Director, Robert Friel, To Board

* WEST PHARMACEUTICAL SERVICES - BOARD HAS ELECTED ROBERT FRIEL AS ITS NEWEST MEMBER

BRIEF-West Announces Q4 Earnings Per Share $0.84

* Q4 EARNINGS PER SHARE ESTIMATE $0.72 -- REFINITIV IBES DATA

BRIEF-West Announces Board Approved Q4 Dividend Of $0.15/Share

* WEST ANNOUNCES THIRD-QUARTER DIVIDEND, INCREASE TO FOURTH-QUARTER DIVIDEND AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

BRIEF-West Announces Q1 Earnings Per Share $0.58

* Q1 EARNINGS PER SHARE VIEW $0.64 -- THOMSON REUTERS I/B/E/S

BRIEF-West Chief Financial Officer William Federici Announces Plans To Retire

* WEST CHIEF FINANCIAL OFFICER WILLIAM FEDERICI ANNOUNCES PLANS TO RETIRE

BRIEF-West Pharmaceutical Reports Q4 Adjusted Earnings Per Share $0.64

* WEST ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS AND ANNOUNCES QUARTERLY DIVIDEND

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up